Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion type Assertion NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_head.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion description "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_provenance.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion evidence source_evidence_literature NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_provenance.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion SIO_000772 21343549 NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_provenance.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion wasDerivedFrom befree-20150227 NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_provenance.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion wasGeneratedBy ECO_0000203 NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_provenance.